The Federal Court has dealt US drug giant Merck Sharp & Dohme a devastating blow, overturning an “untenable” patent term extension which would have protected the monopoly of its multibillion-dollar Januvia and Janumet diabetes drugs beyond July 2o22.
A leading Sydney silk who has appeared for the prosecution in a high-profile criminal cartel case over a $2.5 billion ANZ share placement is set to become New South Wales’ first woman to serve as Director of Public Prosecutions.
The applicant in a class action on behalf of hundreds of thousands of Colonial First State Investments customers has raised concerns about whether he can recover compensation from a CBA life insurance unit that was recently sold to a competitor.
A former Maurice Blackburn lawyer set to give evidence in a suit against Qantas was not “deliberately avoiding” the trial with an extended hospital stay, but “better evidence” was needed for why he was admitted, a judge has said.
A BP worker who was awarded $201,000 after he was unlawfully dismissed for sharing a Hitler parody video has lost his bid for $51,000 in costs from his employer and law firm Corrs Chambers Westgarth.
A court has ruled that labour hire firm CoreStaff cannot rely on its professional indemnity insurance to cover judgment against it in an employment class action alleging itmisled workers who relocated from Papua New Guinea to Australia for work.
A former tenured professor is seeking $2 million from the University of New South Wales, alleging she was terminated after making complaints about discrimination, bullying and misuse of her intellectual property.
Westpac has released further details of its fraud claim against Bill Papas, founder of the Forum Group of Companies, painting a picture of an elaborate scheme to misappropriate $254 million to buy real estate, jewellery, luxury cars, racehorses and European football teams.
Baker McKenzie has been accused of negligence in a cross claim by Chinese lender Aoyin, which faces a lawsuit by accounting giant PricewaterhouseCoopers for unpaid fees over advice related to a failed bid to launch a bank in Australia.
A plastic surgeon who was subjected to an “online tirade of criticism, negative reviews and abuse” by a former patient has won $450,000 in defamation damages.